Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Change in Account Payables of -$1.6 million for Q1 2026, down 550.14% year-over-year from $361000.0 in Q1 2025, and down 175.34% quarter-over-quarter from $2.2 million in Q4 2025.
Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Change in Account Payables for 7 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 550.14% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$424000.0 (up 76.41% YoY), while the FY2025 annual figure was $1.6 million, up 206.33% from the prior year.
- Change in Account Payables eased to -$1.6 million in Q1 2026 per IPSC's latest filing, from $2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.0 million in Q3 2023 and bottomed at -$3.0 million in Q1 2023.
- Historically, Change in Account Payables has averaged -$510647.1 across 5 years, with a median of -$591000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 465.72% — and 2026, when it slumped 550.14%.
- Century Therapeutics' Change in Account Payables stood at -$1.6 million in 2022, then sank by 76.79% to -$2.9 million in 2023, then surged by 116.52% to $477000.0 in 2024, then jumped by 352.2% to $2.2 million in 2025, then slumped by 175.34% to -$1.6 million in 2026.
- Business Quant data shows IPSC's Change in Account Payables at -$1.6 million in Q1 2026, $2.2 million in Q4 2025, and -$591000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | -1.63 Mn |
| Mar 31, 2026 | -1.63 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | -591,000.00 |
| Sep 30, 2025 | -591,000.00 |
| Jun 30, 2025 | -365,000.00 |
| Jun 30, 2025 | -365,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | -757,000.00 |
| Sep 30, 2024 | -757,000.00 |
| Jun 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | 689,000.00 |
| Mar 31, 2024 | 689,000.00 |